CymitQuimica logo

MNKI-85

CAS:

Ref. 3D-MXC88557

25mg
765.00€
50mg
1,153.00€
100mg
1,603.00€
MNKI-85
Biosynth

Product Information

Name:MNKI-85
Brand:Biosynth
Description:MNKI-85 is a small molecule that inhibits the activity of the mapk protein kinase and has minimal toxicity. MNKI-85 induces tumor regression in animal models and is being developed for the treatment of cancer. MNKI-85 induces apoptotic cell death by inhibiting translation, cellular transformation, and tumorigenesis. This drug also reduces leukemia cells by inhibiting protein synthesis and causing apoptotic cell death. Clinical trials are currently underway to assess the efficacy of this drug in patients with cancer.
Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:418.49 g/mol
Formula:C20H23FN4O3S
Purity:Min. 95%

Technical inquiry about: MNKI-85

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
◻️
CYMIT QUÍMICA, S.L. as responsible for the treatment will treat your data in order to respond to your queries or requests. You can access, rectify and delete your data, as well as exercise other rights by consulting the additional and detailed information on data protection in our Web Privacy Policy.
* Mandatory fields.